ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 300289 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 300289; 2) Community: the network communities that were significantly associated with the response to NSC 300289; 3) Molecule: the relationships between components within communities and NSC 300289; 4) MDR: the compounds that were significantly associated with the NSC 300289.

NSC Compound Enrichment Correlation
NSC 684838 Propanamide, 3,3,3-trifluoro-2-(trifluoromethyl)- N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- 0.0147237897640499 0.069923011
NSC 691251 Null 0.0147237897640499 0.34787561
NSC 734294 Indenoisoquinoline derivative 0.0147237897640499 0.69472826
NSC 734562 6-(3-Aminopropyl)-9-bromo-5,6-dihydro-3-nitro-5,11-dioxo-11H -indeno[1,2-c]isoquinoline Hydrochloride 0.0147237897640499 0.54014311
NSC 740276 5,6-Dihydro-6-[3-(hydroxyethyl)amino-1-propyl]-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloide 0.0147237897640499 0.69330989
NSC 33568 1-Propanone, 1,2-diphenyl-3-(1-piperidinyl)- (9CI) 0.0164116791870034 0.12222063
NSC 46598 Null 0.0164116791870034 0.15536564
NSC 56452 Null 0.0164116791870034 0.32700227
NSC 606172 Camptothecin Derivative 0.0164116791870034 0.6259903
NSC 613327 Gemcitabine Y 0.0164116791870034 0.52535786
Total:92  Current:38    [First] [Prev] [Next] [Last]